Neurodevelopmental disorders (NDDs) are increasingly relevant to life insurers as diagnostic rates rise and recognition extends into adulthood.
Historically framed as childhood-onset disorders characterized by deficits in cognition, behavior, or social functioning, these conditions are now understood as persistent neurobiological variations with diverse clinical trajectories.1
In parallel, the concept of neurodiversity has reframed these conditions as part of the natural variation in human cognition. For insurers, this perspective does not diminish risk considerations but emphasizes that outcomes are shaped by the interaction between neurobiological traits, comorbid conditions, and environmental context.2
From a risk perspective, NDDs are less important as discrete diagnoses than as indicators of broader behavioral, psychiatric, and medical profiles.
NDDs encompass a group of conditions with onset in early development, affecting cognitive, behavioral, and social functioning. Common conditions include attention-deficit/hyperactivity disorder (ADHD), autism spectrum disorder, specific learning disorder, and Tourette syndrome.2
Prevalence estimates suggest that up to one in seven individuals may be neurodivergent.2 These conditions frequently co-occur and exist along a spectrum of severity and functional impact.
It is clinically useful to distinguish between traits and disorders. Functional impairment can emerge when traits interact with comorbidity, environmental demands, and/or insufficient supports.
The long-term course and trajectory of NDDs are highly variable. While some individuals experience an attenuation of symptoms, others demonstrate persistence into adulthood. Key prognostic factors include symptom severity, cognitive and adaptive functioning, comorbid psychiatric conditions, and environmental supports and early intervention.3
Comorbidity is a central driver of risk. Common co-occurring conditions include major depressive disorder, generalized anxiety disorder, substance use disorder, and obsessive-compulsive disorder.4 Additional associations include conditions such as Ehlers-Danlos syndrome, postural orthostatic tachycardia syndrome, and irritable bowel syndrome, suggesting broader multisystem complexity in some individuals.5
NDDs frequently persist into adulthood, although the presentation evolves. Many individuals learn to compensate effectively, while others experience a variety of ongoing functional challenges. Observed patterns may include educational attainment below expected levels, employment variability or underemployment, and increased absenteeism.3 At the same time, strengths such as creativity, adaptability, and high engagement in dynamic environments are common and increasingly recognized. Mental health and behavioral factors, including substance use, sleep disruption, and impulsivity, remain key contributors to long-term outcomes.3,4
Individuals with ADHD show elevated mortality risk, with life expectancy reductions of approximately six to nine years in some cohorts.6,7 Excess mortality appears largely driven by modifiable factors, including accidental injury, substance use, cardiovascular risk, and suicide. The risk of accidental death is approximately two-fold higher, reflecting inattention, impulsivity, and comorbid conditions.6
Emerging evidence also suggests increased cardiovascular risk (HR ~1.5-1.7), although causality remains uncertain and under investigation.8 Risk does not arise from ADHD itself, but from the cascade of downstream effects, many of which are modifiable and responsive to intervention. Table 1 illustrates a simplified pathway linking neurodevelopmental traits to insurance-relevant outcomes.
The neurodiversity framework emphasizes variation, rather than deficit. For insurers, this supports a more nuanced interpretation of risk.2
Diagnosis alone has limited predictive value. We know that risk assessment is better informed by functional and behavioral indicators. Rising diagnosis rates reflect increased awareness and broader criteria, but that also introduces greater heterogeneity and reinforces the need for individualized assessment. Table 2 summarizes key domains relevant to underwriting risk stratification.
NDDs often present as non-visible conditions. A functional assessment should focus on attention and executive functioning, emotional regulation, task completion, and fit with occupational demands.
Effective strategies for intervention and support may include psychological interventions (e.g., CBT-based approaches, coaching), pharmacological treatment, workplace accommodations, and management of comorbid conditions.4,9 The appropriateness, intensity, and cadence of intervention will vary by individual, influenced by case-specific factors and the interplay of comorbid conditions. Table 3 outlines a practical framework for functional assessment in claims adjudication. This framework supports a shift from diagnosis-based adjudication to functional capacity-based evaluation, improving consistency in claims duration and return-to-work decision-making.
Overlap with mood and anxiety disorders may complicate diagnosis and treatment, underscoring the importance of careful clinical assessment.1 Current key gaps in understanding and areas for further research include the long-term cardiovascular and cancer risk,5 impact of early intervention on lifetime outcomes, role of digital interventions, and interactions with the social determinants of health.3,8
Neurodevelopmental disorders are increasingly relevant to life insurers, not as isolated diagnoses but as markers of broader risk profiles. A nuanced approach – integrating clinical understanding with a neurodiversity-informed perspective – supports improved risk selection, more effective claims management, and alignment with evolving clinical and societal perspectives. Moving toward function-based assessment allows insurers to better capture both risk and resilience, enhancing decision-making in an increasingly complex landscape.
RGA experts are eager to engage with clients to better understand and tackle the industry’s most pressing challenges together. Contact us to learn more about RGA's capabilities, resources, and solutions.
